TEO breaks out of deep falling wedge from half its value earlier in year. * Paid a 17.45% dividend last year and known for double digit dividends * Telecom 5G play for new subscribers in 2019, or watch until 2019 entry at higher price, likely near $30. * Growing mid-cap telecom, cable, cellular provider * Fell out of favor on negative earnings miss building...
LNG The LNG market has has some scales of economies to reduce production and processing costs. Cheniere Energy was Cheniere Energy Partners' revenues went from $270 million in 2015 to $1.1 billion in 2016. They took another leap in 2017, rising to $4.3 billion, and over $5.8B in expected in 2018 to handle growing pace as demand for lower cost energy like...
NCS NCI is a near $2B business, which just merged with Ply Gem Corp. also $2B business forming larger construction and engineered products business * Forming handle in likely break from Fibretrace 0.786 at $15.75 to $17.00 indicating break-out * Drop to 14.10 not likely as relative strength and sales growth in construction and housing products after Hurricane...
Watch CCI momentum with MACD here. . . future profits and earnings TBD. Await patents and studies. Expect they'll eventually have to sell the farm here to pay for all the cannabis / hemp studies. Ent Value / Mkt Value is 1.02. A new medical advisory board for new medical products. One patent issued 2017 for treatment of neurobahaviors and could lead to...
TWTR Fibretracement for 27.50 or 22.50 entry. Watch for longbuylongsell and 1w chart here, change to 1d/4h for best entry with CCI and MACD (volume)
ALOT is showing a resistance in supply/demand in buyers with more selling on 4h chart. Fibretracement 0.786 would drop to $20.75-20.80 or more likely $19.20-19.35 resistance zone areas as better buy. Watch the black change to blue on 4h or 1d chart for entrance, which is currently black. @MarxBabu for longbuylongsell chart adding MACD, volume, volume...
SIN is out of favor solid growth oil stock. * Pays a 7.2% dividend yearly to owners the end of June in July. * Entry below 5 year trend resistance line and discounted. * EPS is increasing at 40% * Dividends are increasing near double digits, so next year will be higher than 7.2% * Long term dividends will allow great 1x / year payout * 27% revenue change yr...
CBDS Entry $4.5275 with crossing MACD just below 0, upward CCI. For own reference.
Bespoke is a CBD Oil from HEMP stock with all the dressings to grow, but was bubble busted over the past few weeks. Watching to buy only when 1) MACD crosses 0 and 2) CCI going into upward buy point (see earlier circled period ), or see area's for shorting. This stock simply was overvalued, oversold, and over-pumped by billionaire hoping to get rich pumping...
Heavy pounding on this one and good entry at 0.50 on Fib regression.
Buying in for LONG at $29
NCAP is growing at 166% sales growth, however likely growth is with legalization. Watch and follow microcap software IT for eventual play. 2014 RETURNs play. Pick & Shovel stock Wish they'd diversify software focus to medical marijuana & CBD side, instead of all fun & games. #missingthebigpicture VC phase, earnings -0.01 to none as positive.
CV Sciences repeats 2014. The boat is starting to rock, get in or get out. CBD Oil, Cannabis, Medical - Bioceutical Cannabis, reducing opioids, etc. No megatrend here...what am I saying. Time to see who's at the helm though. Viewers come to own conclusions here.
NMUS About: NEMUS Bioscience, Inc. ( NMUS ) , focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need. Entry better on 4h / 1d vs 1w chart here and another CBD stock missed entry for self note. Watching to see if breakout from current level. Future entry TBD. Watch...
About: ICC Labs ICCLF ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada. Blocked at the border? Break-out Aug...
EVIO Labs is another micro small-cap cannabis lab test & research co. Entry at $0.70 and getting bounce to T1 / T2 for exit. Not profitable or I'd stay longer. Gaining position. Targets both on Fib retracement unless something changes. One of 3 approved test facilities in MA, and already in CA, OR, and WA.
NYSE:SQM * Lithium play * USD/Bolivian currency.... * Mining play * Sequencing watch * Break out from downward wedge * Discount on Lithium levearaging USD
Hudson Bay Minerals is 50% off January high and mining not favorite for many but it's in small-cap under $10 stocks that can give good double digits this year. Turning up off baseline entry as copper futures are also turning around.